Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application, please contact our technical support staff.
Visit our FAQ
Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888
Product Categories
Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.

852A is a toll-like receptor 7 (TLR7) agonist.1 It selectively induces NF-κB signaling in HEK293 cells expressing recombinant human TLR7 but not HEK293 cells expressing recombinant human TLR8 or TLR9 when used at a concentration of 1 µM. 852A (10-1,000 ng/ml) also induces IFN-α production in plasmacytoid dendritic cell-enriched but not plasmacytoid dendritic cell-depleted isolated human peripheral blood mononuclear cells (PBMCs). In vivo, 852A (150 mg/kg) delays the onset of lung metastasis in a B16/F10 murine melanoma model.2
WARNING This product is not for human or veterinary use.
1. First in human phase I trial of 852A, a novel systemic toll-
2. TLR7 agonist 852A inhibition of tumor cell proliferation is dependent on plasmacytoid dendritic cells and type I IFN. J. Interferon Cytokine Res. 28(4), 253-263 (2008).